A Study to Assess the Metabolism, Excretion, and Mass Balance of Radio-Labeled Plazomicin
Completed · Phase 1
Conditions studied: Healthy Volunteers
In brief
This is a single-center, open label, non-randomized metabolism, excretion, and mass balance study of a single IV infusion of \[14C\]-plazomicin in healthy, adult male subjects.
Key facts
- Study ID
- NCT03177278
- Run by
- Achaogen, Inc.
- People needed
- 6
- Starts
- 2017-06-16
- Expected to finish
- 2017-07-10
- Last updated by the study team
- 2017-07-12
Who can join
Age: 19 and older, up to 55. Sex: male. Healthy volunteers: accepted.
Where it is running
- Clinical Site — Lincoln, Nebraska, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.